

- 3.10.2026
- Press Releases
VETS Co-Founder & CEO Amber Capone Named to Inc.'s 2026 Female Founders 500 List for Second Consecutive Year
Amber Capone, co-founder and CEO of VETS, has been named to Inc.’s 2026 Female Founders 500 List for the second consecutive year, recognizing her leadership in advancing research, policy reform, and expanded access to psychedelic-assisted therapies for veterans.

- 1.22.2026
- Press Releases
New Jersey Governor Signs Psilocybin Therapy Bill Into Law, Advancing Evidence-Based Treatment Options for Mental Health
This groundbreaking initiative will enable psilocybin-assisted therapy trials at three hospitals across the state. VETS played a pivotal role in advancing this legislation.

- 1.7.2026
- Press Releases
Press Release: Eliza Dushku, Mental Health Counselor and Former Actress, Joins VETS Board of Directors
VETS welcomes former actress and clinical mental health specialist Eliza Dushku to its Board of Directors, bringing her expertise in psychedelic-assisted therapy and unwavering commitment to veteran mental health to further VETS’ mission of ending the veteran suicide epidemic.

- 10.15.2025
- Press Releases
California Governor Newsom Signs AB 1103 to Accelerate Psychedelic Research for Veterans and Mental Health Innovation
Legislation sponsored by VETS will expedite critical research on psychedelic therapies for PTSD, traumatic brain injury, and substance use disorders in California